Top Markets
#1 Black Phoenix Black Phoenix +166.18%
#2 Islamic Coin Islamic Coin +158.21%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.80%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.53%
#6 MarsCoin MarsCoin +13.34%
#7 Test Test +12.58%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +11.52%
#9 Palladium Network Palladium Network +9.76%
#10 Useless Coin Useless Coin +9.21%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.

InNexus Biotechnology, Inc.

IXSBF
Classement en actions #41697
InNexus Biotechnology, Inc. is a development-stage company dedicated to... InNexus Biotechnology, Inc. is a development-stage company dedicated to advancing and commercializing monoclonal antibodies. Its efforts are underpinned by its proprietary Dynamic Cross Linking (DXL) technology. This DXL platform is designed to boost the therapeutic efficacy of conventional monoclonal antibody treatments by strengthening their binding to target antigens, amplifying their effector functions, and endowing them with novel properties. InNexus's development portfolio features several investigational therapies: DXL625: A monoclonal antibody currently in late-stage pre-clinical development, engineered for superior binding kinetics and enhanced effector functions, intended for treating B-cell non-Hodgkin's lymphoma (NHL). DXLr120: A recombinant DXL anti-CD20 antibody also being developed for B-cell NHL. DXL702: A monoclonal antibody targeting metastatic breast cancer. DXL1218: An agent designed to target the epidermal growth factor receptor (EGFR), an antigen frequently overexpressed in metastatic colorectal cancer and squamous cell carcinomas of the head and neck. The company also maintains strategic partnerships with XERIS Pharmaceuticals, Genhelix, Evogenix, Affimed, and Corixa. InNexus Biotechnology, Inc. is based in Vancouver, Canada.
Prix de l'action
$0.0001
Dernière synchronisation: 2025-11-07
Capitalisation boursière
$12.63K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
CA
Échange InNexus Biotechnology, Inc. (IXSBF)

Catégorie

Healthcare
Le prix IXSBF avec la capitalisation boursière de B
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.
IXSBF
$0.0001
Capitalisation boursière de InNexus Biotechnology, Inc.(IXSBF)
Capitalisation boursière: $12.63K
En August 2026, InNexus Biotechnology, Inc. a une capitalisation boursière de $12.63K. Cela fait de InNexus Biotechnology, Inc. la 41697th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de InNexus Biotechnology, Inc. du 2005 au 2026
IXSBF par rapport au top 5 des plus populaires stocks
Prix pour IXSBF L’actif B La capitalisation boursière de B Résultats
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.
$42,633.72 $12.63K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +42,633,717,014.12%
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.
$35,031.21 $12.63K
Apple Inc. Apple Inc.
AAPL
$4.423T +35,031,212,410.79%
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.
$32,948.20 $12.63K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +32,948,201,365.76%
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.
$29,011.81 $12.63K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +29,011,806,639.53%
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.
$22,897.19 $12.63K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +22,897,194,763.39%